Caption Management’s Guardant Health GH Stock Holding History

Caption Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-282,500	Closed	-$17.7M	–	1759
2025 Q3	$17.7M	Buy	+282,500	New	+$15.4M	0.14%	161
2025 Q2	–	Sell	-82,400	Closed	-$3.51M	–	1631
2025 Q1	$3.51M	Buy	+82,400	New	+$3.56M	0.03%	503
2024 Q4	–	Sell	-150,700	Closed	-$3.46M	–	1594
2024 Q3	$3.46M	Hold	150,700	–	–	0.06%	393
2024 Q2	$4.35M	Buy	150,700 +117,400	+353%	+$2.73M	0.07%	290
2024 Q1	$687K	Buy	+33,300	New	+$714K	0.01%	819
2022 Q4	–	Sell	-504,300	Closed	-$27.1M	–	1420
2022 Q3	$27.1M	Buy	504,300 +474,300	+1,581%	+$24.4M	0.37%	47
2022 Q2	$1.21M	Buy	+30,000	New	+$1.49M	0.02%	816
2022 Q1	–	Sell	-1,300	Closed	-$130K	–	1634
2021 Q4	$130K	Buy	+1,300	New	+$134K	﹤0.01%	1464
2020 Q1	–	Sell	-90,000	Closed	-$7.03M	–	933
2019 Q4	$7.03M	Buy	+90,000	New	+$6.49M	0.24%	107

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Caption Management's GH Position: Q2 2026 in Review

Caption Management sold out of Guardant Health (GH) in Q2 2026, closing a stake of 115,183 shares — an estimated $10.6M sold.

Caption Management first reported a position in GH in Q4 2019 and held it in 12 quarters. The position peaked at $10.6M in Q1 2026. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Caption Management reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
Caption Management sold 115,183 Guardant Health shares in Q2 2026, an estimated $10.6M.
Caption Management first reported a position in Guardant Health in Q4 2019 and held it in 12 quarters.
Caption Management's Guardant Health position peaked at $10.6M in Q1 2026.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.